Author
Listed:
- James E. Barrett
(Universität Innsbruck, Innsbruck
University College London
Universität Innsbruck)
- Chiara Herzog
(Universität Innsbruck, Innsbruck
Universität Innsbruck)
- Allison Jones
(University College London)
- Olivia C. Leavy
(University of Leicester
London School of Hygiene and Tropical Medicine)
- Iona Evans
(University College London)
- Susanne Knapp
(University College London)
- Daniel Reisel
(University College London)
- Tatiana Nazarenko
(University College London)
- Yoo-Na Kim
(Universität Innsbruck, Innsbruck
Universität Innsbruck)
- Dorella Franchi
(Istituto Europeo di Oncologia, IRCCS)
- Andy Ryan
(University College London)
- Joanna Franks
(Breast Service, University College London Hospital)
- Line Bjørge
(Haukeland University Hospital
Department of Clinical Science, University of Bergen)
- Michal Zikan
(First Faculty of Medicine, Charles University in Prague, University Hospital Bulovka)
- David Cibula
(Charles University in Prague, General University Hospital in Prague)
- Nadia Harbeck
(University of Munich (LMU))
- Nicoletta Colombo
(Istituto Europeo di Oncologia, IRCCS
University of Milano-Bicocca)
- Frank Dudbridge
(University of Leicester
London School of Hygiene and Tropical Medicine)
- Louise Jones
(Barts Cancer Institute, Queen Mary University of London)
- Karin Sundström
(Division of Pathology, Karolinska Institutet)
- Joakim Dillner
(Division of Pathology, Karolinska Institutet)
- Angelique Flöter Rådestad
(Karolinska Institutet and Karolinska University Hospital)
- Kristina Gemzell-Danielsson
(Karolinska Institutet and Karolinska University Hospital)
- Nora Pashayan
(University College London)
- Martin Widschwendter
(Universität Innsbruck, Innsbruck
University College London
Universität Innsbruck
Karolinska Institutet and Karolinska University Hospital)
Abstract
Genetic and non-genetic factors contribute to breast cancer development. An epigenome-based signature capturing these components in easily accessible samples could identify women at risk. Here, we analyse the DNA methylome in 2,818 cervical, 357 and 227 matched buccal and blood samples respectively, and 42 breast tissue samples from women with and without breast cancer. Utilising cervical liquid-based cytology samples, we develop the DNA methylation-based Women’s risk IDentification for Breast Cancer index (WID-BC-index) that identifies women with breast cancer with an AUROC (Area Under the Receiver Operator Characteristic) of 0.84 (95% CI: 0.80–0.88) and 0.81 (95% CI: 0.76–0.86) in internal and external validation sets, respectively. CpGs at progesterone receptor binding sites hypomethylated in normal breast tissue of women with breast cancer or in BRCA mutation carriers are also hypomethylated in cervical samples of women with poor prognostic breast cancer. Our data indicate that a systemic epigenetic programming defect is highly prevalent in women who develop breast cancer. Further studies validating the WID-BC-index may enable clinical implementation for monitoring breast cancer risk.
Suggested Citation
James E. Barrett & Chiara Herzog & Allison Jones & Olivia C. Leavy & Iona Evans & Susanne Knapp & Daniel Reisel & Tatiana Nazarenko & Yoo-Na Kim & Dorella Franchi & Andy Ryan & Joanna Franks & Line Bj, 2022.
"The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples,"
Nature Communications, Nature, vol. 13(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-021-27918-w
DOI: 10.1038/s41467-021-27918-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-021-27918-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.